✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Gufic Biosciences Ltd.

GUFICBIO

Market Cap
₹3,843 Cr.
P/E
46.88

Gufic Biosciences Ltd.

  • Gufic Biosciences
  • Sequent Scientific
  • Orchid Pharma
  • TJI Pharma - Small Cap
FAQs on Gufic Biosciences Ltd. Shareprice

Gufic Biosciences has given better returns compared to its competitors.
Gufic Biosciences has grown at ~15.2% over the last 7yrs while peers have grown at a median rate of 12.64%

Yes, Gufic Biosciences is expensive.
Latest PE of Gufic Biosciences is 46.88, while 3 year average PE is 33.24.
Also latest EV/EBITDA of Gufic Biosciences is 28.81 while 3yr average is 20.03.

View FAQ's On Business
Growth Table
  • Gufic Biosciences Ltd.
  • Sequent Scientific
  • Orchid Pharma
Balance Sheet
  • Gufic Biosciences Ltd.
  • Sequent Scientific
  • Orchid Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Gufic Biosciences Ltd.
  • Sequent Scientific
  • Orchid Pharma
Cash Flow
  • Gufic Biosciences Ltd.
  • Sequent Scientific
  • Orchid Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Gufic Biosciences Ltd.
  • Sequent Scientific
  • Orchid Pharma
Quarterly Results
  • Gufic Biosciences Ltd.
  • Sequent Scientific
  • Orchid Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Gufic Biosciences Ltd. Financials

Balance sheet of Gufic Biosciences is strong.
It shouldn't have solvency or liquidity issues.

The debt of Gufic Biosciences is decreasing.
Latest debt of Gufic Biosciences is ₹264 Crs as of Sep-24.
This is less than Mar-24 when it was ₹291 Crs.

The profit is oscillating.
The profit of Gufic Biosciences is ₹81.98 Crs for TTM, ₹86.14 Crs for Mar 2024 and ₹79.7 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Gufic Biosciences latest dividend payout ratio is 1.16% and 3yr average dividend payout ratio is 1.13%

Companies resources are allocated to majorly unproductive assets like Capital Work in Progress, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech